These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Carnitine deficiency with valproate therapy. Stumpf DA; Parker WD; Haas R J Pediatr; 1983 Jul; 103(1):175-6. PubMed ID: 6408234 [No Abstract] [Full Text] [Related]
24. Does carnitine administration improve the symptoms attributed to anticonvulsant medications?: a double-blinded, crossover study. Freeman JM; Vining EP; Cost S; Singhi P Pediatrics; 1994 Jun; 93(6 Pt 1):893-5. PubMed ID: 8190572 [TBL] [Abstract][Full Text] [Related]
25. Carnitine deficiency: Risk factors and incidence in children with epilepsy. Fukuda M; Kawabe M; Takehara M; Iwano S; Kuwabara K; Kikuchi C; Wakamoto H; Morimoto T; Suzuki Y; Ishii E Brain Dev; 2015 Sep; 37(8):790-6. PubMed ID: 25547040 [TBL] [Abstract][Full Text] [Related]
26. Hyperammonemia due to valproic acid in the psychiatric setting. Carr RB; Shrewsbury K Am J Psychiatry; 2007 Jul; 164(7):1020-7. PubMed ID: 17606652 [No Abstract] [Full Text] [Related]
31. The syndrome of carnitine deficiency. Di Donato S; Cornelio F Riv Patol Nerv Ment; 1976 Aug; 97(4):181-5. PubMed ID: 1032033 [TBL] [Abstract][Full Text] [Related]
32. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method. Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814 [TBL] [Abstract][Full Text] [Related]
33. L-carnitine replacement therapy in chronic valproate treatment. Melegh B; Kerner J; Acsádi G; Lakatos J; Sándor A Neuropediatrics; 1990 Feb; 21(1):40-3. PubMed ID: 2107456 [TBL] [Abstract][Full Text] [Related]
35. Valproate-associated carnitine deficiency and malignant cerebral edema in the absence of hepatic failure. Triggs WJ; Gilmore RL; Millington DS; Cibula J; Bunch TS; Harman E Int J Clin Pharmacol Ther; 1997 Sep; 35(9):353-6. PubMed ID: 9314085 [TBL] [Abstract][Full Text] [Related]
36. Serum carnitine levels in epileptic children before and during treatment with valproic acid, carbamazepine, and phenobarbital. Castro-Gago M; Eirís-Puñal J; Novo-Rodríguez MI; Couceiro J; Camiña F; Rodríguez-Segade S J Child Neurol; 1998 Nov; 13(11):546-9. PubMed ID: 9853647 [TBL] [Abstract][Full Text] [Related]
37. Valproate-induced hyperacute hyperammonemic coma in a patient with hypocarnitinemia. Sofi A; Herial NA; Ali II Am J Ther; 2013; 20(6):e703-5. PubMed ID: 20224318 [TBL] [Abstract][Full Text] [Related]
38. Carnitine as an antidote for acute valproate toxicity in children. Russell S Curr Opin Pediatr; 2007 Apr; 19(2):206-10. PubMed ID: 17496767 [TBL] [Abstract][Full Text] [Related]
39. [Evaluation of the effect of long term valproic acid treatment on plasma levels of carnitine, ammonia and amino acids related to the urea cycle in pediatric epileptic patients]. Navarro-Quesada FJ; Lluch-Fernández MD; Vaquero-Abellán M; Marchante-Serrano C; Jiménez C Rev Neurol; 1997 Jul; 25(143):1037-44. PubMed ID: 9280630 [TBL] [Abstract][Full Text] [Related]